Medifast (MED) Q2 comes in-line on a per share basis but misses on revenue.
Net revenue increased 4% Y/Y.
Revenue in the direct sales channel, Take Shape for Life, increased 10% to $61.4M, driven by increased customer product sales and improvements in its pricing and discounting structure.
Medifast Direct channel revenue decreased 4% to $21.5M Y/Y, compared to $22.5M in Q212.
Weight Control Centers and Wholesale Physicians channel revenue decreased 8% to $14.2M, while same store sales for corporate centers opened greater than one year decreased 20% from the prior year period.
Q3 net revenue is expected to be in the range of approximately $93M to $96M.
Q3 EPS is expected to be in the range of $0.38 to $0.42.
For FY13, the company narrows net revenue guidance to $375M to $385M and maintains its EPS guidance of $1.70 to $1.80.